Galileo - Biotech Innovation Fund IM Fonds
101,95
USD
+2,42
USD
+2,43
%
NAV
Werbung
Werbung
Top Holdings
| Name | ISIN | Anteil |
|---|---|---|
| Krystal Biotech Inc | US5011471027 | 9,70% |
| Arcellx Inc | US03940C1009 | 7,39% |
| Alnylam Pharmaceuticals Inc | US02043Q1076 | 4,05% |
| 4D Molecular Therapeutics Inc Ordinary Shares | US35104E1001 | 4,00% |
| Stoke Therapeutics Inc | US86150R1077 | 3,77% |
| Sarepta Therapeutics Inc | US8036071004 | 3,66% |
| Rocket Pharmaceuticals Inc | US77313F1066 | 3,51% |
| Silence Therapeutics PLC ADR | US82686Q1013 | 3,04% |
| Voyager Therapeutics Inc | US92915B1061 | 2,80% |
| Iovance Biotherapeutics Inc | US4622601007 | 2,53% |
| Sonstige | 55,55% |